<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Springer-Verlag</PublisherName>
    <PublisherLocation>New York</PublisherLocation>
  </PublisherInfo>
  <Journal>
    <JournalInfo JournalProductType="ArchiveJournal" NumberingStyle="Unnumbered">
      <JournalID>12248</JournalID>
      <JournalElectronicISSN>1550-7416</JournalElectronicISSN>
      <JournalTitle>The AAPS Journal</JournalTitle>
      <JournalAbbreviatedTitle>AAPS J</JournalAbbreviatedTitle>
      <JournalSubjectGroup>
        <JournalSubject Code="F" Type="Primary">Pharmacy</JournalSubject>
        <JournalSubject Code="F00008" Priority="1" Type="Secondary">Pharmacy</JournalSubject>
        <JournalSubject Code="B21007" Priority="2" Type="Secondary">Pharmacology/Toxicology</JournalSubject>
        <JournalSubject Code="C12002" Priority="3" Type="Secondary">Biotechnology</JournalSubject>
      </JournalSubjectGroup>
    </JournalInfo>
    <Volume>
      <VolumeInfo TocLevels="0" VolumeType="Regular">
        <VolumeIDStart>7</VolumeIDStart>
        <VolumeIDEnd>7</VolumeIDEnd>
        <VolumeIssueCount>4</VolumeIssueCount>
      </VolumeInfo>
      <Issue IssueType="Regular">
        <IssueInfo TocLevels="0">
          <IssueIDStart>2</IssueIDStart>
          <IssueIDEnd>2</IssueIDEnd>
          <IssueArticleCount>25</IssueArticleCount>
          <IssueHistory>
            <CoverDate>
              <Year>2005</Year>
              <Month>6</Month>
            </CoverDate>
          </IssueHistory>
          <IssueCopyright>
            <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
            <CopyrightYear>2005</CopyrightYear>
          </IssueCopyright>
        </IssueInfo>
        <Article ID="Art25">
          <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
            <ArticleID>72496</ArticleID>
            <ArticleDOI>10.1208/aapsj070250</ArticleDOI>
            <ArticleSequenceNumber>25</ArticleSequenceNumber>
            <ArticleTitle Language="En">Further advances in the synthesis of endocannabinoid-related ligands</ArticleTitle>
            <ArticleFirstPage>E496</ArticleFirstPage>
            <ArticleLastPage>E502</ArticleLastPage>
            <ArticleHistory>
              <RegistrationDate>
                <Year>2008</Year>
                <Month>1</Month>
                <Day>23</Day>
              </RegistrationDate>
              <Received>
                <Year>2005</Year>
                <Month>1</Month>
                <Day>22</Day>
              </Received>
              <Accepted>
                <Year>2005</Year>
                <Month>2</Month>
                <Day>9</Day>
              </Accepted>
            </ArticleHistory>
            <ArticleCopyright>
              <CopyrightHolderName>American Association of Pharmaceutical Scientists</CopyrightHolderName>
              <CopyrightYear>2005</CopyrightYear>
            </ArticleCopyright>
            <ArticleGrants Type="Regular">
              <MetadataGrant Grant="OpenAccess"/>
              <AbstractGrant Grant="OpenAccess"/>
              <BodyPDFGrant Grant="Restricted"/>
              <BodyHTMLGrant Grant="Restricted"/>
              <BibliographyGrant Grant="Restricted"/>
              <ESMGrant Grant="Restricted"/>
            </ArticleGrants>
            <ArticleContext>
              <JournalID>12248</JournalID>
              <VolumeIDStart>7</VolumeIDStart>
              <VolumeIDEnd>7</VolumeIDEnd>
              <IssueIDStart>2</IssueIDStart>
              <IssueIDEnd>2</IssueIDEnd>
            </ArticleContext>
          </ArticleInfo>
          <ArticleHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1" CorrespondingAffiliationID="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Anu</GivenName>
                  <FamilyName>Mahadevan</FamilyName>
                </AuthorName>
                <Contact>
                  <Phone>(781) 932-4142</Phone>
                  <Fax>(781) 933-6695</Fax>
                  <Email>mahadevan@organixinc.com</Email>
                </Contact>
              </Author>
              <Author AffiliationIDS="Aff1">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Raj</GivenName>
                  <GivenName>K.</GivenName>
                  <FamilyName>Razdan</FamilyName>
                </AuthorName>
              </Author>
              <Affiliation ID="Aff1">
                <OrgName>Organix, Inc.</OrgName>
                <OrgAddress>
                  <Street>240 Salem Street</Street>
                  <Postcode>01801</Postcode>
                  <City>Woburn</City>
                  <State>MA</State>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1" Language="En">
              <Heading>Abstract</Heading>
              <Para>Recent advances in the synthesis of endocannabinoid-related ligands for the period 2001–2004 are covered in this review. During this period the first solid phase synthesis of anandamide (AEA) analogs was developed, which allows modification at both the head group and the end pentyl chain. Synthesis of water-soluble prodrugs of noladin, ether was reported, which are chemically stable, rapidly release noladin ether under enzymatic conditions and are shown to reduce intraocular pressure. The structure-activity relationships (SAR) of alkylcarbamic acid aryl esters and the discovery of potent, archidonylsulfonyl derivatives as fatty acid amide hydrolase (FAAH) inhibitors are summarized. Recent synthetic developments in the controversial area of anandamide membrane transporter (AMT) inhibitors are also discussed.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>Keywords</Heading>
              <Keyword>endocannabinoids</Keyword>
              <Keyword>synthesis</Keyword>
              <Keyword>structure-activity relationship</Keyword>
            </KeywordGroup>
            <ArticleNote Type="Misc">
              <SimplePara>Published: October 5, 2005</SimplePara>
            </ArticleNote>
          </ArticleHeader>
          <BodyRef FileRef="BodyRef/PDF/12248_2008_Article_72496.pdf" TargetType="OnlinePDF"/>
          <ArticleBackmatter>
            <Bibliography ID="Bib1">
              <Heading>References</Heading>
              <Citation ID="CR1">
                <CitationNumber>1.</CitationNumber>
                <BibBook>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <BookTitle>Cannabinoids</BookTitle>
                  <PublisherName>Plenum Publishers</PublisherName>
                  <PublisherLocation>New York</PublisherLocation>
                </BibBook>
                <BibUnstructured>Di Marzo V.<Emphasis Type="Italic">Cannabinoids</Emphasis>. New York: Plenum Publishers, 2004.</BibUnstructured>
              </Citation>
              <Citation ID="CR2">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Petrocellis</FamilyName>
                    <Particle>De</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D</Initials>
                    <FamilyName>Melck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Cannabimimetic fatty acid derivatives: the anandamide family and other “endocannabinoids”</ArticleTitle>
                  <JournalTitle>Curr Med Chem.</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>721</FirstPage>
                  <LastPage>744</LastPage>
                </BibArticle>
                <BibUnstructured>Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Martin BR. Cannabimimetic fatty acid derivatives: the anandamide family and other “endocannabinoids”.<Emphasis Type="Italic">Curr Med Chem.</Emphasis> 1996;6:721–744.</BibUnstructured>
              </Citation>
              <Citation ID="CR3">
                <CitationNumber>3.</CitationNumber>
                <BibBook>
                  <BibEditorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibEditorName>
                  <Eds/>
                  <Year>1995</Year>
                  <BookTitle>Cannabinoid Receptors</BookTitle>
                  <PublisherName>Academic Press Ltd</PublisherName>
                  <PublisherLocation>London, UK</PublisherLocation>
                </BibBook>
                <BibUnstructured>Pertwee RG, ed.<Emphasis Type="Italic">Cannabinoid Receptors</Emphasis>. London, UK: Academic Press Ltd; 1995.</BibUnstructured>
              </Citation>
              <Citation ID="CR4">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Pharmacology of cannabinoid CB<Subscript>1</Subscript> and CB<Subscript>2</Subscript> receptors</ArticleTitle>
                  <JournalTitle>Pharmacol Ther.</JournalTitle>
                  <VolumeID>74</VolumeID>
                  <FirstPage>129</FirstPage>
                  <LastPage>180</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9336020</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0163-7258(97)82001-3</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXkvFChsL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pertwee RG. Pharmacology of cannabinoid CB<Subscript>1</Subscript> and CB<Subscript>2</Subscript> receptors.<Emphasis Type="Italic">Pharmacol Ther.</Emphasis> 1997;74:129–180.</BibUnstructured>
              </Citation>
              <Citation ID="CR5">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RG</Initials>
                    <FamilyName>Pertwee</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Pharmacology of cannabinoid receptor ligands</ArticleTitle>
                  <JournalTitle>Curr Med Chem.</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>635</FirstPage>
                  <LastPage>664</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10469884</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXltlKkurg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pertwee RG. Pharmacology of cannabinoid receptor ligands.<Emphasis Type="Italic">Curr Med Chem.</Emphasis> 1999;6:635–664.</BibUnstructured>
              </Citation>
              <Citation ID="CR6">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>WA</Initials>
                    <FamilyName>Devane</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>FA</Initials>
                    <FamilyName>Dysarz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MR</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>LS</Initials>
                    <FamilyName>Melvin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Howlett</FamilyName>
                  </BibAuthorName>
                  <Year>1988</Year>
                  <ArticleTitle Language="En">Determination and characterization of a cannabinoid, receptor in rat brain</ArticleTitle>
                  <JournalTitle>Mol Pharmacol.</JournalTitle>
                  <VolumeID>34</VolumeID>
                  <FirstPage>605</FirstPage>
                  <LastPage>613</LastPage>
                  <Occurrence Type="PID">
                    <Handle>2848184</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaL1MXovVersQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Devane WA III, Dysarz FA, III, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid, receptor in rat brain.<Emphasis Type="Italic">Mol Pharmacol.</Emphasis> 1988;34:605–613.</BibUnstructured>
              </Citation>
              <Citation ID="CR7">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Munro</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KL</Initials>
                    <FamilyName>Thomas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Abu-Shaar</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Molecular characterization of a peripheral receptor for cannabinoids</ArticleTitle>
                  <JournalTitle>Nature</JournalTitle>
                  <VolumeID>365</VolumeID>
                  <FirstPage>61</FirstPage>
                  <LastPage>65</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7689702</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1038/365061a0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXmsVWiurk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids.<Emphasis Type="Italic">Nature</Emphasis>. 1993;365:61–65.</BibUnstructured>
              </Citation>
              <Citation ID="CR8">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rinaldi-Carmona</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Barth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Heaulme</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">SR141716A, a potent and selective antagonist of the brain cannabinoid receptor</ArticleTitle>
                  <JournalTitle>FEBS Lett.</JournalTitle>
                  <VolumeID>350</VolumeID>
                  <FirstPage>240</FirstPage>
                  <LastPage>244</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8070571</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/0014-5793(94)00773-X</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2cXmsVKjsrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rinaldi-Carmona M, Barth F, Heaulme M, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor.<Emphasis Type="Italic">FEBS Lett.</Emphasis> 1994;350:240–244.</BibUnstructured>
              </Citation>
              <Citation ID="CR9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Rinaldi-Carmona</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F</Initials>
                    <FamilyName>Barth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Millan</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>284</VolumeID>
                  <FirstPage>644</FirstPage>
                  <LastPage>650</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9454810</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXhtFWkt78%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rinaldi-Carmona M, Barth F, Millan J, et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 1998;284:644–650.</BibUnstructured>
              </Citation>
              <Citation ID="CR10">
                <CitationNumber>10.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>BR</Initials>
                    <FamilyName>Martin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mechoulam</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RK</Initials>
                    <FamilyName>Razdan</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Discovery and characterization of endogenous cannabinoids</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>573</FirstPage>
                  <LastPage>595</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10462059</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0024-3205(99)00281-7</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXkslOltr4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Martin BR, Mechoulam R, Razdan RK. Discovery and characterization of endogenous cannabinoids.<Emphasis Type="Italic">Life Sci.</Emphasis> 1999;65:573–595.</BibUnstructured>
              </Citation>
              <Citation ID="CR11">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Hanus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Abu-Lafi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Fride</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">2-Arachidonylglyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor</ArticleTitle>
                  <JournalTitle>Proc. Natl Acad Sci USA</JournalTitle>
                  <VolumeID>98</VolumeID>
                  <FirstPage>3662</FirstPage>
                  <LastPage>3665</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11259648</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.061029898</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXis1KitbY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Hanus L, Abu-Lafi S, Fride E, et al. 2-Arachidonylglyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor.<Emphasis Type="Italic">Proc. Natl Acad Sci USA</Emphasis>. 2001;98:3662–3665.</BibUnstructured>
              </Citation>
              <Citation ID="CR12">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AC</Initials>
                    <FamilyName>Porter</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JM</Initials>
                    <FamilyName>Sauer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MD</Initials>
                    <FamilyName>Knierman</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor</ArticleTitle>
                  <JournalTitle>J Pharmacol Exp Ther.</JournalTitle>
                  <VolumeID>301</VolumeID>
                  <FirstPage>1020</FirstPage>
                  <LastPage>1024</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12023533</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1124/jpet.301.3.1020</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XktlGjsLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Porter AC, Sauer JM, Knierman MD, et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.<Emphasis Type="Italic">J Pharmacol Exp Ther.</Emphasis> 2002;301:1020–1024.</BibUnstructured>
              </Citation>
              <Citation ID="CR13">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SM</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Bisogno</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Trevisani</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors</ArticleTitle>
                  <JournalTitle>Proc Natl Acad Sci USA</JournalTitle>
                  <VolumeID>99</VolumeID>
                  <FirstPage>8400</FirstPage>
                  <LastPage>8405</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12060783</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.122196999</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XkvVGnsLo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Huang SM, Bisogno T, Trevisani M. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis> 2002;99:8400–8405.</BibUnstructured>
              </Citation>
              <Citation ID="CR14">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Sheskin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Hanus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Slager</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z</Initials>
                    <FamilyName>Vogel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Mechoulam</FamilyName>
                  </BibAuthorName>
                  <Year>1997</Year>
                  <ArticleTitle Language="En">Structural requirements for binding of anandamide type compounds to the brain cannabinoid, receptor</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>40</VolumeID>
                  <FirstPage>659</FirstPage>
                  <LastPage>667</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9057852</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm960752x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2sXhsFWns7k%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sheskin T, Hanus L, Slager J, Vogel Z, Mechoulam R. Structural requirements for binding of anandamide type compounds to the brain cannabinoid, receptor.<Emphasis Type="Italic">J Med Chem.</Emphasis> 1997;40:659–667.</BibUnstructured>
              </Citation>
              <Citation ID="CR15">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>AD</Initials>
                    <FamilyName>Khanolkar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Makriyannis</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Structure-activity relationships of anandamide, an endogenous cannabinoid ligand</ArticleTitle>
                  <JournalTitle>Life Sci.</JournalTitle>
                  <VolumeID>65</VolumeID>
                  <FirstPage>607</FirstPage>
                  <LastPage>616</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10462061</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0024-3205(99)00283-0</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXkslOltrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Khanolkar AD, Makriyannis A. Structure-activity relationships of anandamide, an endogenous cannabinoid ligand.<Emphasis Type="Italic">Life Sci.</Emphasis> 1999;65:607–616.</BibUnstructured>
              </Citation>
              <Citation ID="CR16">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>RK</Initials>
                    <FamilyName>Razdan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Mahadevan</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Recent advances in the synthesis of endocannabinoid related ligands</ArticleTitle>
                  <JournalTitle>Chem Phys Lipids</JournalTitle>
                  <VolumeID>121</VolumeID>
                  <FirstPage>21</FirstPage>
                  <LastPage>33</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12505687</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0009-3084(02)00142-1</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38Xpslansrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Razdan RK, Mahadevan A. Recent advances in the synthesis of endocannabinoid related ligands.<Emphasis Type="Italic">Chem Phys Lipids</Emphasis>. 2002;121:21–33.</BibUnstructured>
              </Citation>
              <Citation ID="CR17">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Altundas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Mahadevan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>RK</Initials>
                    <FamilyName>Razdan</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">A synthetic route to anandamide analogues canying a substituent at the teminal carbon and an acetylene group in the end pentyl chain</ArticleTitle>
                  <JournalTitle>Tetrahedron Lett</JournalTitle>
                  <VolumeID>45</VolumeID>
                  <FirstPage>5449</FirstPage>
                  <LastPage>5451</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.tetlet.2004.05.071</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXkvFygur0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Altundas R, Mahadevan A, Razdan RK. A synthetic route to anandamide analogues canying a substituent at the teminal carbon and an acetylene group in the end pentyl chain.<Emphasis Type="Italic">Tetrahedron Lett</Emphasis>. 2004;45:5449–5451.</BibUnstructured>
              </Citation>
              <Citation ID="CR18">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Qi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>MM</Initials>
                    <FamilyName>Meijler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S-H</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C</Initials>
                    <FamilyName>Sun</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>KD</Initials>
                    <FamilyName>Janda</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Solid-phase synthesis of anandamide analogues</ArticleTitle>
                  <JournalTitle>Org Lett.</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>1673</FirstPage>
                  <LastPage>1675</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15128264</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/ol049474j</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXjt1Ggs70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Qi L, Meijler MM, Lee S-H, Sun C, Janda KD. Solid-phase synthesis of anandamide analogues.<Emphasis Type="Italic">Org Lett.</Emphasis> 2004;6:1673–1675.</BibUnstructured>
              </Citation>
              <Citation ID="CR19">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Parkkari</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JR</Initials>
                    <FamilyName>Savinainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>AL</Initials>
                    <FamilyName>Rauhala</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett.</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>3231</FirstPage>
                  <LastPage>3234</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15149681</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bmcl.2004.03.093</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXktVertL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Parkkari T, Savinainen JR, Rauhala AL, et al. Synthesis and CB1 receptor activities of novel arachidonyl alcohol derivatives.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2004;14:3231–3234.</BibUnstructured>
              </Citation>
              <Citation ID="CR20">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>SE</Initials>
                    <FamilyName>Fangour</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L</Initials>
                    <FamilyName>Balas</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J-C</Initials>
                    <FamilyName>Rossi</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>1977</FirstPage>
                  <LastPage>1980</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12781177</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fangour SE, Balas L, Rossi J-C, et al. Hemisynthesis and preliminary evaluation of novel endocannabinoid analogues.<Emphasis Type="Italic">Bioorg Med Chem Lett</Emphasis>. 2003;13:1977–1980.</BibUnstructured>
              </Citation>
              <Citation ID="CR21">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Juntunen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J</Initials>
                    <FamilyName>Vepsalainen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R</Initials>
                    <FamilyName>Niemi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K</Initials>
                    <FamilyName>Laine</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T</Initials>
                    <FamilyName>Jarvinen</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>5083</FirstPage>
                  <LastPage>5086</LastPage>
                  <Occurrence Type="PID">
                    <Handle>14584958</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm030877j</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXntlyqtbk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Juntunen J, Vepsalainen J, Niemi R, Laine K, Jarvinen T. Synthesis, in vitro evaluation, and intraocular pressure effects of water-soluble prodrugs of endocannabinoid noladin ether.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2003;46:5083–5086.</BibUnstructured>
              </Citation>
              <Citation ID="CR22">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Tarzia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Duranti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Tontini</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors</ArticleTitle>
                  <JournalTitle>J Med Chem</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>2352</FirstPage>
                  <LastPage>2360</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12773040</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm021119g</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXjs12ksL0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tarzia G, Duranti A, Tontini A, et al. Design, synthesis, and structure-activity relationships of alkylcarbamic acid aryl esters, a new class of fatty acid amide hydrolase inhibitors.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2003;46:2352–2360.</BibUnstructured>
              </Citation>
              <Citation ID="CR23">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Mor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Rivara</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Lodola</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>47</VolumeID>
                  <FirstPage>4998</FirstPage>
                  <LastPage>5008</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15456244</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm031140x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXntFGhs7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Mor M, Rivara S, Lodola A, et al. Cyclohexylcarbamic acid 3′- or 4′-substituted biphenyl-3-yl esters as fatty acid amide hydrolase inhibitors: synthesis, quantitative structure-activity relationships, and molecular modeling studies.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2004;47:4998–5008.</BibUnstructured>
              </Citation>
              <Citation ID="CR24">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>Y</Initials>
                    <FamilyName>Segall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>GB</Initials>
                    <FamilyName>Quistad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>DK</Initials>
                    <FamilyName>Nomura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>JE</Initials>
                    <FamilyName>Casida</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem Lett.</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>3301</FirstPage>
                  <LastPage>3303</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12951114</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/S0960-894X(03)00721-2</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmvV2ltLw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Segall Y, Quistad GB, Nomura DK, Casida JE. Arachidonylsulfonyl derivatives as cannabinoid CB1 receptor and fatty acid amide hydrolase inhibitors.<Emphasis Type="Italic">Bioorg Med Chem Lett.</Emphasis> 2003;13:3301–3303.</BibUnstructured>
              </Citation>
              <Citation ID="CR25">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Lopez-Rodriguez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ortega-Gutierrez</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The anandamide degradation system as potential targets for the treatment of central nervous system related disorders</ArticleTitle>
                  <JournalTitle>Curr Med Chem Cent Nerv Syst Agents</JournalTitle>
                  <VolumeID>4</VolumeID>
                  <FirstPage>155</FirstPage>
                  <LastPage>160</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.2174/1568015043356959</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmsFCisrc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lopez-Rodriguez ML, Ortega-Gutierrez S. The anandamide degradation system as potential targets for the treatment of central nervous system related disorders.<Emphasis Type="Italic">Curr Med Chem Cent Nerv Syst Agents</Emphasis>. 2004;4:155–160.</BibUnstructured>
              </Citation>
              <Citation ID="CR26">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V</Initials>
                    <FamilyName>Marzo</FamilyName>
                    <Particle>Di</Particle>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Ligresti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E</Initials>
                    <FamilyName>Morera</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M</Initials>
                    <FamilyName>Nalli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G</Initials>
                    <FamilyName>Ortar</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">The anandamide membrane transporter. Structure-activity relationships of anadamide and oleoylethanolamine analogs with phenyl rings in the polar head group region</ArticleTitle>
                  <JournalTitle>Bioorg Med Chem.</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>5161</FirstPage>
                  <LastPage>5169</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15351399</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.bmc.2004.07.026</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Di Marzo V, Ligresti A, Morera E, Nalli M, Ortar G. The anandamide membrane transporter. Structure-activity relationships of anadamide and oleoylethanolamine analogs with phenyl rings in the polar head group region.<Emphasis Type="Italic">Bioorg Med Chem.</Emphasis> 2004;12:5161–5169.</BibUnstructured>
              </Citation>
              <Citation ID="CR27">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>ML</Initials>
                    <FamilyName>Lopez-Rodriguez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A</Initials>
                    <FamilyName>Viso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S</Initials>
                    <FamilyName>Ortega-Gutierrez</FamilyName>
                  </BibAuthorName>
                  <Etal/>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase</ArticleTitle>
                  <JournalTitle>J Med Chem.</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <FirstPage>1512</FirstPage>
                  <LastPage>1522</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12672252</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1021/jm0210818</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXitVOlsL4%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lopez-Rodriguez ML, Viso A, Ortega-Gutierrez S, et al. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.<Emphasis Type="Italic">J Med Chem.</Emphasis> 2003;46:1512–1522.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ArticleBackmatter>
        </Article>
      </Issue>
    </Volume>
  </Journal>
</Publisher>
